WASHINGTON UNIVERSITY SCHOOL OF MEDICINE

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private, Subsidiary

Established: 1891-01-01

Employees: 10K

Market Cap: -

Website: http://www.medschool.wustl.edu

Clinical Trials

Effect of Moderate Weight Loss in Metabolically Abnormal Lean Subjects

Not Applicable

Withdrawn

Conditions: Weight Loss

Interventions: Other: Moderate (8-10%) diet-induced weight loss

First Posted Date: 2015-05-22

Last Posted Date: 2021-05-28

Lead Sponsor: Washington University School of Medicine

Registration Number: NCT02452567

Locations: 🇺🇸
Washington University School of Medicine, Saint Louis, Missouri, United States

Allogeneic Stem Cell Transplantation for Patients With Multiple Myeloma

Early Phase 1

Withdrawn

Conditions: Multiple Myeloma
Myeloma-Multiple

Interventions: Biological: Tocilizumab
Drug: Melphalan
Drug: Fludarabine
Drug: Cyclophosphamide
Drug: Tacrolimus
Drug: Mycophenolate mofetil
Drug: Filgrastim

First Posted Date: 2015-05-18

Last Posted Date: 2016-07-12

Lead Sponsor: Washington University School of Medicine

Registration Number: NCT02447055

Cracking the Egg Potential: Improving Young Child Nutrition in Ecuador

Not Applicable

Completed

Conditions: Vitamin B-12 Deficiency
Amino Acids Deficiency
Lipids Deficiency
Choline Deficiency

Interventions: Other: Egg supplementation

First Posted Date: 2015-05-18

Last Posted Date: 2018-06-19

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 171

Registration Number: NCT02446873

Locations: 🇪🇨
Pastocalle Parish, Pastocalle, Cotopaxi Province, Ecuador

Diabetes Group Prenatal Care

Not Applicable

Completed

Conditions: Gestational Diabetes
Pregnancy
Type 2 Diabetes

Interventions: Behavioral: Group prenatal care

First Posted Date: 2015-05-14

Last Posted Date: 2018-01-05

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 84

Registration Number: NCT02444325

Locations: 🇺🇸
Washington University in St. Louis, Saint Louis, Missouri, United States
🇺🇸
Denver Health, Denver, Colorado, United States

The Feasibility of a Prehabilitation Program in the Liver Transplant Population at Barnes-Jewish Hospital

Not Applicable

Completed

Conditions: Physical Activity
End Stage Liver Disease

Interventions: Procedure: Exercise

First Posted Date: 2015-05-14

Last Posted Date: 2018-05-11

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 101

Registration Number: NCT02444273

Comparing Ketamine and Morphine in the Treatment of Acute Fracture Pain

Not Applicable

Terminated

Conditions: Acute Pain
Fractures

Interventions: Drug: ketamine
Drug: morphine

First Posted Date: 2015-04-30

Last Posted Date: 2019-05-22

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 13

Registration Number: NCT02430818

Locations: 🇺🇸
Barnes Jewish Hospital, Saint Louis, Missouri, United States

Genomic Landscape of EGFR Mutant NSCLC Prior to Erlotinib and at the Time of Disease Progression

Terminated

Conditions: Nonsmall Cell Lung Cancer
Non-Small Cell Lung Cancer
Carcinoma, Non-Small-Cell-Lung

First Posted Date: 2015-04-30

Last Posted Date: 2019-07-18

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 5

Registration Number: NCT02431169

Locations: 🇺🇸
Washington University School of Medicine, Saint Louis, Missouri, United States

Safety and Immunogenicity of a Personalized Synthetic Long Peptide Breast Cancer Vaccine Strategy in Patients With Persistent Triple-Negative Breast Cancer Following Neoadjuvant Chemotherapy

Phase 1

Withdrawn

Conditions: Triple Negative Breast Cancer
Triple Negative Breast Neoplasms
Triple-Negative Breast Cancer

Interventions: Biological: Personalized synthetic long peptide vaccine (Poly ICLC)
Drug: Poly ICLC

First Posted Date: 2015-04-28

Last Posted Date: 2022-03-10

Lead Sponsor: Washington University School of Medicine

Registration Number: NCT02427581

Mature Dendritic Cell Vaccination Against Unique Immunogenic Peptides in Patients With Non Small Cell Lung Cancer (NSCLC)

Early Phase 1

Withdrawn

Conditions: Nonsmall Cell Lung Cancer
Carcinoma, Non-Small-Cell-Lung
Non-Small Cell Lung Cancer

Interventions: Procedure: Standard of care surgery
Procedure: Apheresis
Drug: Cyclophosphamide
Biological: Personalized mature dendritic cell vaccine

First Posted Date: 2015-04-17

Last Posted Date: 2016-07-18

Lead Sponsor: Washington University School of Medicine

Registration Number: NCT02419170

PET Imaging of Natriuretic Peptide Receptor C (NPR-C) in Carotid Atherosclerosis

Phase 1

Completed

Conditions: Carotid Atherosclerosis

Interventions: Device: Cu[64]-25%-CANF-Comb PET-MR

First Posted Date: 2015-04-16

Last Posted Date: 2022-10-17

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 44

Registration Number: NCT02417688

Locations: 🇺🇸
Washington University in St.Louis, Saint Louis, Missouri, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy